Abstract

In the May 2021 issue of Thyroid (vol. 31, no. 5; pp.821–828), the article entitled “Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy” by Vannucchi, et al. requires correction.
The fifth affiliation previously attributed to author Davide Soranna has been updated and has also been added as an affiliation to author Antonella Zambon.
The article originally published as:
Guia Vannucchi,1 Irene Campi,1 Danila Covelli,2 Nicola Currò,3 Elisa Lazzaroni,2 Andrea Palomba,4 Davide Soranna,5 Antonella Zambon,4 Laura Fugazzola,1 Ilaria Muller,2 Claudio Guastella,6 and Mario Salvi2
5Istituto Auxologico Italiano IRCCS, Milan, Italy.
The article has been revised to:
Guia Vannucchi,1 Irene Campi,1 Danila Covelli,2 Nicola Currò,3 Elisa Lazzaroni,2 Andrea Palomba,4 Davide Soranna,5
5
The online version has been corrected to reflect this. The authors apologize for this error.
